Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
1 hedge funds and large institutions have $5.99K invested in Biotricity, Inc. Common Stock in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
62% less capital invested
Capital invested by funds: $15.7K → $5.99K (-$9.73K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFAM
Sawyer Falduto Asset Management
Elmhurst,
Illinois
|
-$4.33K |
BTCY Hedge Fund Activity: Q2 2026 in Review
1 institutional investor reported a position in Biotricity, Inc. Common Stock (BTCY) for Q2 2026, worth a combined $5.99K — down 62% from $15.7K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BTCY and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Sawyer Falduto Asset Management, exiting entirely with an estimated $4.33K sold.
- 1 institutional investor held Biotricity, Inc. Common Stock (BTCY) as of Q2 2026, down from 2 in Q1 2026.
- Funds reported $5.99K of Biotricity, Inc. Common Stock stock for Q2 2026, down 62% quarter-over-quarter.
- 0 funds opened new Biotricity, Inc. Common Stock positions in Q2 2026 and 1 closed out, a net change of -1 holder.
- The largest Biotricity, Inc. Common Stock seller in Q2 2026 was Sawyer Falduto Asset Management, an estimated $4.33K sold.
Based on aggregated 13F filings for Q2 2026.